Business Strategy - The company is developing plans to create billion-dollar medications from cannabis and mushrooms [1] Industry Focus - The industry is exploring the potential of cannabis and mushrooms in the pharmaceutical sector [1]

Check out Forbes' fourth-annual Cannabis 42.0 list to see the pot pioneers blazing a path forward in 2025. https://t.co/UIjCkjjOFO https://t.co/UIjCkjjOFO ...

Forbes 2025 Cannabis 42.0 List https://t.co/8mS4c8CQTV https://t.co/8mS4c8CQTV ...

Industry Focus - The cannabis and psychedelic medicine industries are converging, with companies exploring the potential of both cannabis and mushrooms to create billion-dollar medications [1] Company Strategy - Companies are developing plans to create medications from cannabis and mushrooms [1]

Business Strategy - The company is developing plans to create billion-dollar medications from cannabis and mushrooms [1] Industry Focus - The industry is exploring the potential of cannabis and mushrooms in the pharmaceutical sector [1]

Business Strategy - The company is developing plans to create billion-dollar medications from cannabis and mushrooms [1] Industry Focus - The industry is exploring the potential of cannabis and mushrooms in the pharmaceutical sector [1]

Industry Focus - The CBD industry leaders are developing plans to create billion-dollar medications from cannabis and mushrooms [1]

Business Strategy - The company plans to develop billion-dollar medications from cannabis and mushrooms [1] Industry Focus - The industry is shifting towards the development of pharmaceuticals using cannabis and mushrooms [1]

Business Strategy - The company is developing plans to create billion-dollar medications from cannabis and mushrooms [1] Industry Focus - The industry is exploring the potential of cannabis and mushrooms in the pharmaceutical sector [1]

The Kings Of CBD Are Now Cooking Up Plans To Make Billion-Dollar Meds From Cannabis And Mushrooms https://t.co/4W2de2WW6w https://t.co/4W2de2WW6w ...